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Extracellular vesicles (EVs) play key roles in transporting key molecular constituents as cargo for
extracellular trafficking. While several approaches have been developed to extract EVs from
mammalian cells, the specific method of EV isolation can have a profound effect on membrane
integrity and yield. Here, we describe a step-by-step procedure to separate EVs from adherent
epithelial cells using differential ultracentrifugation. Separated EVs can be further analyzed by
immunoblotting, mass spectrometry, and transmission electron microscopy to derive EV yield
and morphology.
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SUMMARY
Extracellular vesicles (EVs) play key roles in transporting key molecular constitu-
ents as cargo for extracellular trafficking. While several approaches have been
developed to extract EVs from mammalian cells, the specific method of EV isola-
tion can have a profound effect on membrane integrity and yield. Here, we
describe a step-by-step procedure to separate EVs from adherent epithelial cells
using differential ultracentrifugation. Separated EVs can be further analyzed by
immunoblotting, mass spectrometry, and transmission electron microscopy to
derive EV yield and morphology.
For complete details on the use and execution of this protocol, please refer to
Brown et al. (2019).
BEFORE YOU BEGIN
Preparation of extracellular vesicle (EV)-free serum
Timing: ~1 day
1. Centrifuge serum using SW 32.1 Ti Swinging-Bucket rotor (k-factor = 204) in Optima XPN-80 -
Ultracentrifuge at 22,000 rpm for 140 min at 4C.
2. Sterilize the serum using a 0.22 mm syringe filter.
Note: Steps 1 and 2, serum centrifugation and filter sterilization respectively, are interchangeable.
KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
ALIX, mouse monoclonal Abcam Cat#ab117600; RRID: AB_10899268
CD9, mouse monoclonal Novus Biologicals Cat#NBP2-22187; RRID: AB_1853147
CD63, rabbit monoclonal Abcam Cat#ab217345; RRID: AB_2754982
GM130, rabbit monoclonal Abcam Cat#ab52649; RRID: AB_880266
TSG-101, mouse monoclonal Genetex Cat#GTX70255; Clone: 4A10;
Lot 43353; RRID: AB_373239
Chemicals, peptides, and recombinant proteins
RSL3 SelleckChem Cat#S8155
DMSO Fisher Scientific Cat#BP231
(Continued on next page)
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MATERIALS AND EQUIPMENT
Here, we describe the media components used to culture Hs578t and MCF10A cell lines.
Note: Premix all of the appropriate MCF10A media additives listed above and sterile filter
mixture through a 0.22 mm filter system (Figure 1A).
CRITICAL: Insulin should be adjusted to pH 3 when added to MCF10Amedia as insulin has
low solubility at a neutral pH. We suggest resuspending insulin at 10 mg/mL in sterile H2O
and add either dilute acetic or hydrochloric acid until pH 3.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Experimental models: cell lines
Human normal mammary epithelial,
MCF10A
Barbara Ann Karmanos Cancer
Center
N/A
Human triple negative breast
carcinoma, Hs578T
Laboratory of Dr. Dohoon Kim,
PhD (University of Massachusetts
Medical School)
N/A
Other
Centrifuge 5810 R Eppendorf Cat#022625101
DMEM high glucose medium Gibco Cat#11965118
DMEM/F:12 medium Gibco Cat#11320082
Cholera toxin MilliporeSigma Cat#C8052
EGF Peprotech Cat#AF-100-15
Horse serum, New Zealand origin Gibco Cat#16050
HyClone calf serum, US origin GE Cat#SH30073
Hydrocortisone MilliporeSigma Cat#H4001
Insulin MilliporeSigma Cat#I5500
Open-top Thinwall ultra-clear tubes,
25 3 89 mm
Beckman Coulter Cat#344058
Optima XPN-80 ultracentrifuge Beckman Coulter Cat#A99839
Penicillin-streptomycin (10,000 U/mL) Gibco Cat#15140122
PVDF syringe filter, 0.22 mm, 30 mm CellTreat Cat#229743
Rotor A-4-62, incl. 4 3 250 mL
rectangular buckets
Eppendorf Cat#022638009
SW 32.1 Ti swinging-bucket rotor
and SW 32 Ti rotor bucket set
(k-factor = 204)
Beckman Coulter Cat#369651
TUBE & CAP, 50 mL centrifuge
tube and cap
CellTreat Cat#229421
0.5% Trypsin-EDTA (103) Gibco Cat#15400-54
500 mL filter system, 0.22 mm PES
filter, 90 mm diameter, sterile
CellTreat Cat#229707
MCF10A media
Reagent Stock concentration Final concentration Amount
DMEM/F:12 medium N/A N/A 500 mL
Horse serum N/A 5% 25 mL
EGF 100 mg/mL 20 ng/mL 100 mL
Hydrocortisone 1 mg/mL 0.5 mg/mL 250 mL
Cholera toxin 1 mg/mL 100 ng/mL 50 mL
Insulin 10 mg/mL 10 mg/mL 500 mL
Penicillin/streptomycin 10,000 U/mL 100 U/mL 5 mL
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CRITICAL: It is important to use EV-free serum (e.g., EV-free FBS for Hs578t cells or EV-
free horse serum for MCF10A cells) when preparing media in place of serum as specified
above. Serum contains EVs, which will contaminate cell-derived EVs, and may alter down-
stream readouts (Pavani et al., 2019; Shelke et al., 2014). Extracellular proteins and RNA
present in serummay also co-separate with cell-derived EVs and have significant biological
effects on the cell (Wei et al., 2016).
STEP-BY-STEP METHOD DETAILS
This protocol is aimed at isolating EVs from adherent epithelial cells in cell culture models. The protocol
canbeadapteddependingon the treatment anddesire for further characterization includingmorpholog-
ical analysis, immunoblotting,mass spectrometry, and transmission electronmicroscopy (TEM). Cells are
treated,prepared, andcell culturemedia is collected (1) using standardprocedures.Centrifugationof the
collected cell culturemedia (2) separates EVs fromother extracellularmaterials (Livshits et al., 2015),while
differential ultracentrifugation further enriches and concentrates the EV sample (Yu et al., 2018).
Note: The protocol shown below is described step by step, performed with MCF10A cells
treated with 2.5 mM RSL3 for 18 h, though this protocol may be adapted to other treatments.
Cell culture preparation
Timing: ~1 day
Here, we will be culturing MCF10A cells. Total number of plates will depend on the downstream ap-
plications and desired yield. Given the limited concentration of EVs separated from cell culture me-
dia, we suggest starting with 6–150 3 20 mm TC-treated dishes. This procedure aims to prepare
cells for collection after treatment. Cells are treated with 2.5 mM RSL3 and cell culture media is
collected for EV isolation in the following section.
1. Subculture MCF10A cells. Plate ~750,000 cells in 100 3 20 mm TC-treated dishes. Keep them
in a DMEM/F:12 media consisting of 5% EV-free horse serum, EGF (Final Concentration:
20 ng/mL), hydrocortisone (Final Concentration: 0.5 mg/mL), Cholera Toxin (Final Concentration:
100 ng/mL), insulin (Final Concentration: 10 ug/mL), and 1% Penicillin/Streptomycin.
Note: The number of MCF10A plates is restricted only by the volume limited by the ultracen-
trifugation rotors and tubes. More plates may allow for a greater quantity of separated EVs.
This protocol can be adapted to other cell lines such as the Hs578t cells.
Sample treatment and media collection
Timing: ~1 day
This procedure aims to prepare cells for collection after treatment. Cells are treated with RSL3. Cell
culture media is collected for EV isolation in the following section.
Hs578t media
Reagent Stock concentration Final concentration Amount
DMEM high glucose medium N/A N/A 500 mL
FBS N/A 5% 25 mL
Insulin 2.5 mg/mL 1% 2 mL
Penicillin/streptomycin 10,000 U/mL 100 U/mL 5 mL
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2. Remove media from cells.
Note:We suggest 80%–90% cell confluency at which point media is collected for EV isolation.
Confluency can be adjusted differently depending on the purpose of the experiment; howev-
er, we do not recommend less than 50% cell confluency as this will greatly affect the overall EV
yield/enrichment.
3. Treat cells with 2.5 mM RSL3 for 18 h in EV-free media.
4. Collect cell culture media and transfer into 50 mL conical tubes.
CRITICAL: Following cell culture media collection, it is necessary to keep samples on ice at
all times to avoid EV degradation (Cheng et al., 2019).
EV isolation
Timing: 5–6 h
Here, differential centrifugation and ultracentrifugation are utilized to separate EVs from cell com-
ponents (e.g., cells, cell debris, and cellular organelles). Figure 2 emphasizes the major centrifuga-
tion and ultracentrifugation steps of this protocol for ease of use.
5. Place 50 mL conical tubes into Rotor A-4-62 and pellet down cells by centrifuging tubes in Centri-
fuge 5810 R at 1,000 rpm for 5 min at 4C.
6. Discard pellet and transfer supernatant into new 50 mL conical tubes.
7. Centrifuge tubes in Centrifuge 5810 R at 3,000 rpm for 10 min at 4C (Figure 1B).
Note: While samples are in centrifuge, we suggest turning on/setting Optima XPN-80 to 4C
and placing SW 32.1 Ti Swinging-Bucket rotor in cold room to allow sufficient time for
pre-cooling.
Figure 1. Extracellular vesicle separation by ultracentrifugation step-by-step method overview
(A) Media filter sterilization (0.22 mm filter) for subculturing cells.
(B) MCF10A cell pellet after centrifugation at 3,000 rpm for 10 min at 4C.
(C) Two ultracentrifugation tubes balanced with media and using cold PBS as necessary. Ultracentrifuge tubes are filled to avoid collapse as a result of
insufficient volume.
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8. Discard pellet and transfer supernatant into new 50 mL conical tubes.
9. Centrifuge tubes in Centrifuge 5810 R at 4,000 rpm for 30 min at 4C.
10. Transfer supernatant into ultracentrifuge tubes.
CRITICAL: Be cautious when transferring supernatant in steps 6, 8, and 10 (centrifugation
steps) because the pellets contain cells, dead cells, and cell debris, which will contaminate
the EV pellet. The use of a portable pipette controller is recommended until ~5 mL media
remain in centrifuge tube to minimize disturbances to cell pellet. The remaining media
should be collected using P200 and P1000 pipettes.
11. Place ultracentrifuge tubes into pre-cooled SW 32.1 Ti Swinging-Bucket rotor and centrifuge
tubes in Optima XPN-80 Ultracentrifuge at 22,000 rpm for 140 min at 4C.
Note: Ultracentrifuge tubes should remain balanced. Use cold PBS and add to ultracentrifuge
tube with media (Figure 1C).
CRITICAL: It is necessary to fill ultracentrifuge tubes to a sufficient volume, as the tubes
may collapse and limit the ability to recover EV sample.
Figure 2. Illustrative extracellular vesicle isolation protocol overview
After cell culture preparation and sample treatment, the media is collected and undergoes two phases for EV isolation and enrichment: (1)
centrifugation and (2) ultracentrifugation. During (1), cells (alive and dead) and debris are removed. EVs are then separated and enriched in (2). Figure
partially created using BioRender.
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12. Remove media and resuspend pellets in 10 mL cold PBS.
CRITICAL: Do NOT use aspirator to removemedia because this may inadvertently remove
the EV pellet from the ultracentrifuge tube. Instead, remove media by gently pipetting us-
ing P1000 pipette. When ~1–2 mL media remain in the ultracentrifuge tube, use P200
pipette to remove residual media.
13. Centrifuge samples in Optima XPN-80 Ultracentrifuge at 22,000 rpm for 140 min at 4C
14. Carefully aspirate supernatant and resuspend pellet in suitable buffer for further downstream
applications and characterization/identification analyses, such as immunoblot, mass spectrom-
etry, and TEM.
Note: Specific buffer and volume for EV resuspension is dependent on specific down-
stream analyses and applications. For immunoblot and TEM, we suggest resuspending
in 30 mL–50 mL RIPA buffer and cold PBS, respectively, and incubating on ice for
10 min. For ICP-mass spectrometry, we resuspended EV-containing pellet in 0.5 mL PBS
and centrifuged in a SpeedVac vacuum concentrator at 45C. Samples were then digested
in 100 mL HNO3, heated for 20 min at 65C, and diluted to 2 mL with ddH2O before
analysis.
Figure 3. Methods of identification and validation of extracellular vesicles following isolation and enrichment via
ultracentrifugation
Following isolation and enrichment via ultracentrifugation, EV components can be further characterized using
immunoblotting, TEM, and mass spectrometry. Figure partially created using BioRender and Brown et al., 2019.
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Optional: EV-containing pellets can be stored at 80C while maintaining EV membrane
integrity and quality (Lee et al., 2016), though we suggest avoiding repeated freeze/thaw cy-
cles to avert sample degradation.
EXPECTED OUTCOMES
After the centrifugation and ultracentrifugation of the collected cell culture media, this protocol pro-
duced separated EVs from adherent epithelial cell lines. In order to accurately determine the effec-
tiveness and efficacy of this protocol, we encourage the use of further characterization procedures to
assess the presence and purity of the EV sample. Figure 3 highlights several methods that can be
used to identify EVs from adherent epithelial cell culture samples. Of note, while we have used
this protocol extensively for studies mainly in Hs578t and MCF10A cells, we anticipate other
adherent epithelial cell lines to have similar results and outcomes.
Immunoblotting verifies the presence and enrichment of EV-specific biomarkers and may reveal the ex-
istence of contaminants in the sample. Probing for protein expression of key exosomal-specific markers,
such as TSG-101 that are involved inmulti-vesicular body (MVB) synthesis (Raiborg and Stenmark, 2009),
and CD63 that are involved in EV formation (Kowal et al., 2016), supports the enrichment of EVs in the
sample. Detection of non-EV-specific membranemarkers, such as GM130 (Lotvall et al., 2014), suggests
potential contamination and may require further protocol optimization. An immunoblot of expected re-
sults for TSG-101, CD63, and GM130 is presented in Figure 4.
The inclusion of TEM imaging evaluates the overall EV morphology, morphological stability (e.g.,
membrane integrity or disruption), and size distribution profiles. Figure 5 provides an example of
a TEM image, which confirmed the presence of EV within the sample and allowed for single particle
measurements (e.g., diameter and particle-size distribution profiling).
Mass spectrometry (MS) based proteome profiling of EVs can further characterize EV-cargo proteins and
molecules (Bandu et al., 2019), though furtherMS-based analyses should be assessed only after EV char-
acterization recommendations, including immunoblotting and TEM, are met (Coumans et al., 2017 and
Théry et al., 2018). Of note, while we illustrate the procedure to separate extracellular vesicles from cell
culture models using ultracentrifugation, we acknowledge in our previous publication (Brown et al.,
2019) that noMS-basedproteomic datawere produced fromEVpreparations.Oher publishedprotocols
can be used to achieve this objective (Bandu et al., 2019 and Patel et al., 2019).
LIMITATIONS
High volume requirement
While generally considered inexpensive and reliable in terms of reproductivity, isolation of EVs using
ultracentrifugation requires a high sample volume to compensate for the relatively low yield,
Figure 4. Characterization of extracellular vesicle components by immunoblot
Separated EVs from RSL3-treated MCF10A and Hs578t cells were immunoblotted for TSG101, GM130, and CD63. (Figure adapted from Brown et al.,
2019).
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compared to other techniques, such as size-exclusion chromatography and ultrafiltration (Sidhom
et al., 2020). The low-throughput nature of the ultracentrifugation is further restricted by the volume
limitations set by the ultracentrifuge rotors and tubes.
Incomplete isolation of EVs from contaminants
Although we were able to successfully separate EVs, users may still struggle to separate EVs from
other molecules of a similar size and density, such as microvesicles (Yang et al., 2020). While the
absence of non-EV-specific membrane markers, such as GM130 (Lotvall et al., 2014), using immuno-
blotting may suggest isolated EVs, a certain amount of contamination is inherent to each EV sepa-
ration method. Differential ultracentrifugation is widely recognized in co-separating non-EV-associ-
ated high-molecular weight proteins and protein complexes.
Also, the type of rotor utilized during ultracentrifugation can affect the number of lipoproteins, which
can co-separate with other non-EV vesicles (Cvjetkovic et al., 2014). For EV isolation described in this
protocol, we recommend using Beckman Coulter’s SW 32.1 Ti Swinging-Bucket rotor (Cat#369651)
and Optima XPN-80 Ultracentrifuge (Cat#A99839), though others may be sufficient.
Long turn-around time
The ultracentrifugation approach for EV isolation requires a long turn-around time to complete, as
isolation and enrichment of EVs should be followed by identification and characterization of sam-
ples, given potential contamination of particles of similar density and size, such as other lipopro-
teins. While independently not labor intensive, obtaining separated EVs from adherent epithelial
cells coupled with sample characterization via immunoblot and/or mass spectrometry is a disadvan-
tage to the protocol, compared to commercially available EV isolation kits (Patel et al., 2019).
TROUBLESHOOTING
Problem 1
When ultracentrifuge tubes are not filled to a sufficient volume in step 11 and step 13, the tubes may
collapse and limit the ability to recover the EV sample.
Potential solution
We recommend when volume is restricted by insufficient media prior to ultracentrifugation steps to
gently add PBS to the ultracentrifuge tubes. Thin wall ultracentrifuge tubes must be filled to the top
Figure 5. TEM image of separated extracellular vesicles in MCF10A and Hs578t cells
EVs separated from MCF10A and Hs578t cells were imaged by TEM. EVs are shown in black boxes. (Figure adapted
from Brown et al., 2019).
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to prevent tube collapse, while thick wall ultracentrifuge tubes can be filled within 13 mm from the
top.
Problem 2
Difficulty visualizing EV pellet at step 14 while removing supernatant, a critical component to obtain-
ing a concentrated EV sample.
Potential solution
We have found that by gently removing supernatant in circles over a black background, such as a
sheet of black construction paper. When the ultracentrifuge tube is placed over a black background,
the pellet should appear opaque, compared to the clear ultracentrifuge tube. Additionally, EV pellet
visualization difficulties may result from insufficient volume during media collection prior to differen-
tial centrifugation and ultracentrifugation. Potential solutions for this are identified below in Problem
3 under Potential Solution.
Problem 3
Low EV yield/insufficient EV enrichment for immunoblot following step 14.
Potential solution
Though several factors are critical for high EV yields and enrichment for this protocol, we have found
that these were most sensitive to the number of plates cultured in step 1. Preparation of more addi-
tional plates for subculturing cells may increase yields to allow for sufficient protein for immunoblot-
ting; however, this will be restricted by the volume limitations of the ultracentrifuge and rotor. We
have harvested up to 12–150 3 20 mm TC-treated dishes, each with 20 mL of media, at times to
get sufficient EV yield for either immunoblot, mass spectrometry, or TEM.
Cell viability may also be capable of affecting EV biogenesis and secretion. Thus, it may be necessary
to assess cell viability using the Trypan Blue Exclusion test.
RESOURCE AVAILABILITY
Lead contact
Further information and requests for resources and reagents should be directed to and will be ful-
filled by the Lead Contact, Arthur Mercurio (arthur.mercurio@umassmed.edu).
Materials availability
This study did not generate new unique reagents.
Data and code availability
This study did not generate/analyze any dataset or code.
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